TR200101702T2 - Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini. - Google Patents
Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.Info
- Publication number
- TR200101702T2 TR200101702T2 TR2001/01702T TR200101702T TR200101702T2 TR 200101702 T2 TR200101702 T2 TR 200101702T2 TR 2001/01702 T TR2001/01702 T TR 2001/01702T TR 200101702 T TR200101702 T TR 200101702T TR 200101702 T2 TR200101702 T2 TR 200101702T2
- Authority
- TR
- Turkey
- Prior art keywords
- mammaglobin
- breast
- breast cancer
- methods
- cancer protein
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 4
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 4
- 210000000481 breast Anatomy 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Saflastirilmis ve izole edilmis bir DNA dizisi ve salgilanan kodlanmis gögse özgü bir protein, mammaglobin, tarif edilmektedir. Ayrica, gögüs kanseri hücreleri tarafindan mammaglobinin asiri ifadesi ve salgilanmasina göre gögüs kanserinin tespit edilmesi için yöntemler tarif edilmektedir. Yöntemler, mammaglobinin veya mammaglobin kodlayan mRNA'nin mevcudiyetini tespit eder ve miktarini belirler. Ayrica, mammaglobin ifade eden bir tümörü olan bir gögüs kanseri hastasinin tedavi edilmesi için imünoterapiye dayali yöntemler de tarif edilmektedir. Yöntemler tümöre karsi bir humoral ve/veya hücre araciligiyla olan bagisiklik tepkisi indüklemek için mammaglobin antijenlerinin kullanilmasini içerir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/162,622 US6566072B1 (en) | 1995-05-31 | 1998-09-29 | Mammaglobin, a secreted mammary-specific breast cancer protein |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101702T2 true TR200101702T2 (tr) | 2001-12-21 |
Family
ID=22586430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01702T TR200101702T2 (tr) | 1998-09-29 | 1999-09-29 | Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6566072B1 (tr) |
EP (1) | EP1117673A4 (tr) |
JP (1) | JP2002525098A (tr) |
KR (1) | KR20010075418A (tr) |
CN (1) | CN1328567A (tr) |
BR (1) | BR9914161A (tr) |
CA (1) | CA2343980C (tr) |
CZ (1) | CZ20011025A3 (tr) |
HU (1) | HUP0104408A3 (tr) |
IL (1) | IL142079A0 (tr) |
MX (1) | MXPA01003240A (tr) |
NO (1) | NO20011394L (tr) |
PL (1) | PL347021A1 (tr) |
TR (1) | TR200101702T2 (tr) |
WO (1) | WO2000018783A1 (tr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2386854A1 (en) * | 1999-10-07 | 2001-04-12 | Corixa Corporation | Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins |
US7009042B1 (en) * | 1999-10-07 | 2006-03-07 | Corixa Corporation | Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
EP1953246A3 (en) * | 2003-05-01 | 2008-11-19 | Veridex, LLC | Intraoperative lymph node assay |
EP1946118A4 (en) * | 2005-11-10 | 2009-01-21 | Aurelium Biopharma Inc | TISSUE DIAGNOSIS OF BREAST CANCER |
US8790400B2 (en) | 2012-06-13 | 2014-07-29 | Elwha Llc | Breast implant with covering and analyte sensors responsive to external power source |
US9144489B2 (en) | 2012-06-13 | 2015-09-29 | Elwha Llc | Breast implant with covering, analyte sensors and internal power source |
US9144488B2 (en) | 2012-06-13 | 2015-09-29 | Elwha Llc | Breast implant with analyte sensors responsive to external power source |
US8795359B2 (en) | 2012-06-13 | 2014-08-05 | Elwha Llc | Breast implant with regionalized analyte sensors and internal power source |
US8808373B2 (en) | 2012-06-13 | 2014-08-19 | Elwha Llc | Breast implant with regionalized analyte sensors responsive to external power source |
US9211185B2 (en) | 2012-06-13 | 2015-12-15 | Elwha Llc | Breast implant with analyte sensors and internal power source |
CN105548364B (zh) * | 2015-12-10 | 2018-11-02 | 北京理工大学 | 热障涂层结合强度的高阶非线性参数表征方法 |
EP3699595A1 (en) * | 2019-02-22 | 2020-08-26 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Use of bmmf1 rep protein as a biomarker for breast cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
US5573916A (en) | 1994-05-19 | 1996-11-12 | Coretech, Inc. | Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier |
US5668267A (en) | 1995-05-31 | 1997-09-16 | Washington University | Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
US5922836A (en) * | 1995-05-31 | 1999-07-13 | Washington University | Mammaglobin antigens |
WO1998007753A1 (en) * | 1996-08-19 | 1998-02-26 | Abbott Laboratories | Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
CA2270156A1 (en) * | 1996-11-12 | 1998-05-22 | Incyte Pharmaceuticals, Inc. | Human breast tumor-specific proteins |
-
1998
- 1998-09-29 US US09/162,622 patent/US6566072B1/en not_active Expired - Lifetime
-
1999
- 1999-09-29 CZ CZ20011025A patent/CZ20011025A3/cs unknown
- 1999-09-29 HU HU0104408A patent/HUP0104408A3/hu unknown
- 1999-09-29 CA CA2343980A patent/CA2343980C/en not_active Expired - Fee Related
- 1999-09-29 JP JP2000572241A patent/JP2002525098A/ja active Pending
- 1999-09-29 KR KR1020017003944A patent/KR20010075418A/ko not_active Application Discontinuation
- 1999-09-29 TR TR2001/01702T patent/TR200101702T2/tr unknown
- 1999-09-29 EP EP99950003A patent/EP1117673A4/en not_active Withdrawn
- 1999-09-29 PL PL99347021A patent/PL347021A1/xx not_active Application Discontinuation
- 1999-09-29 CN CN99813780A patent/CN1328567A/zh active Pending
- 1999-09-29 WO PCT/US1999/022616 patent/WO2000018783A1/en not_active Application Discontinuation
- 1999-09-29 BR BR9914161-2A patent/BR9914161A/pt not_active Application Discontinuation
- 1999-09-29 IL IL14207999A patent/IL142079A0/xx unknown
- 1999-09-29 MX MXPA01003240A patent/MXPA01003240A/es unknown
-
2001
- 2001-03-19 NO NO20011394A patent/NO20011394L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ20011025A3 (cs) | 2001-09-12 |
CA2343980C (en) | 2012-06-26 |
NO20011394D0 (no) | 2001-03-19 |
US6566072B1 (en) | 2003-05-20 |
EP1117673A4 (en) | 2004-08-04 |
WO2000018783B1 (en) | 2000-05-11 |
BR9914161A (pt) | 2001-06-26 |
CN1328567A (zh) | 2001-12-26 |
WO2000018783A1 (en) | 2000-04-06 |
KR20010075418A (ko) | 2001-08-09 |
JP2002525098A (ja) | 2002-08-13 |
PL347021A1 (en) | 2002-03-11 |
WO2000018783A9 (en) | 2000-09-21 |
EP1117673A1 (en) | 2001-07-25 |
HUP0104408A2 (hu) | 2002-03-28 |
CA2343980A1 (en) | 2000-04-06 |
IL142079A0 (en) | 2002-03-10 |
NO20011394L (no) | 2001-05-22 |
HUP0104408A3 (en) | 2007-05-02 |
MXPA01003240A (es) | 2003-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200003685T1 (tr) | Bir salgılanmış meme kanseri proteini olan mamaglobin | |
TR199701462T1 (tr) | DNA Dizisi ve bununla kodlanmis meme'ye özel gögüs kanseri proteini. | |
TR200101702T2 (tr) | Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini. | |
WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
TR200200937T2 (tr) | Yumurtalık kanseri tedavisi için bileşimler. | |
DE69632536D1 (de) | Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren | |
ATE386804T1 (de) | Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen | |
ATE404669T1 (de) | In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide | |
CY1113064T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 184ρ1ε2 χρησιμα στη θεραπεια και ανιχνευση καρκινου | |
ATE205532T1 (de) | Zellzyklus-unabhängige, gliomaoberflach- spezifische, menschliche monoklonale antikörper | |
DE69720783D1 (de) | Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie | |
ATE152629T1 (de) | Diagnose von krebs-metastasen durch das mts-1 gen | |
DK0454782T3 (da) | Cancer-beslægtet haptaglobin (Hpr.) | |
TR200101141T2 (tr) | Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim | |
MXPA02011563A (es) | Composicionesy metodos para la terapia y diagnostico de cancer de seno. | |
DK1694697T3 (da) | Overfladelokaliserede Campylobacter jejuni-polypeptider | |
EP0495910A4 (en) | Production and use of human nm23 protein and antibodies therefor | |
HK1118861A1 (en) | Genes differentially expressed in breast cancer | |
ATE345503T1 (de) | Krebsdiagnoseverfahren | |
WO2001027276A3 (en) | Dna sequences from breast tumor and uses thereof |